Carl Sailer
Director/Board Member at ACURX PHARMACEUTICALS, INC.
Net worth: 288 002 $ as of 30/03/2024
Profile
Carl V.
Sailer is an Independent Director at Acurx Pharmaceuticals, Inc. and Vice President-Global Client Solutions at Syneos Health, Inc. He was previously Vice President-Sales & Marketing at Emisphere Technologies, Inc., Vice President-Product Commercialization at Interpace Biosciences, Inc., Vice President-Commercial Operations at Akrimax Pharmaceuticals LLC, and Vice President-Product Commercialization at New American Therapeutics, Inc. Sailer holds an MBA from Hofstra University and an undergraduate degree from Seton Hall University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/01/2024 | 117,552 ( 0.81% ) | 288 002 $ | 30/03/2024 |
Carl Sailer active positions
| Companies | Position | Start |
|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Director/Board Member | 22/10/2018 |
| SYNEOS HEALTH, INC. | Corporate Officer/Principal | 30/04/2019 |
Former positions of Carl Sailer
| Companies | Position | End |
|---|---|---|
| EMISPHERE TECHNOLOGIES, INC. | Sales & Marketing | 28/02/2019 |
New American Therapeutics, Inc.
 New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 31/08/2012 |
Akrimax Pharmaceuticals LLC
 Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Corporate Officer/Principal | 30/06/2010 |
| INTERPACE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Training of Carl Sailer
| Hofstra University | Masters Business Admin |
| Seton Hall University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INTERPACE BIOSCIENCES, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Health Technology |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | Health Technology |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
| Acurx Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Carl Sailer
